These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34246298)

  • 21. Creatine and L-carnitine attenuate muscular laminopathy in the LMNA mutation transgenic zebrafish.
    Pan SW; Wang HD; Hsiao HY; Hsu PJ; Tseng YC; Liang WC; Jong YJ; Yuh CH
    Sci Rep; 2024 Jun; 14(1):12826. PubMed ID: 38834813
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Zaragoza MV; Bui TA; Widyastuti HP; Mehrabi M; Cang Z; Sha Y; Grosberg A; Nie Q
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915555
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
    Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
    J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Genes and Pathways Regulated by Lamin A in Heart.
    Coste Pradas J; Auguste G; Matkovich SJ; Lombardi R; Chen SN; Garnett T; Chamberlain K; Riyad JM; Weber T; Singh SK; Robertson MJ; Coarfa C; Marian AJ; Gurha P
    J Am Heart Assoc; 2020 Aug; 9(16):e015690. PubMed ID: 32805188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation.
    Lin EW; Brady GF; Kwan R; Nesvizhskii AI; Omary MB
    FASEB J; 2020 Jul; 34(7):9051-9073. PubMed ID: 32413188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial dilated cardiomyopathy with a novel
    Li K; Zhao L; Zhang P
    Cardiol Young; 2020 Oct; 30(10):1544-1546. PubMed ID: 32914734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
    Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
    BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family.
    Sedaghat-Hamedani F; Rebs S; Kayvanpour E; Zhu C; Amr A; Müller M; Haas J; Wu J; Steinmetz LM; Ehlermann P; Streckfuss-Bömeke K; Frey N; Meder B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
    Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
    Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
    Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
    Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
    Parks SB; Kushner JD; Nauman D; Burgess D; Ludwigsen S; Peterson A; Li D; Jakobs P; Litt M; Porter CB; Rahko PS; Hershberger RE
    Am Heart J; 2008 Jul; 156(1):161-9. PubMed ID: 18585512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
    Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
    J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.
    Arimura T; Helbling-Leclerc A; Massart C; Varnous S; Niel F; Lacène E; Fromes Y; Toussaint M; Mura AM; Keller DI; Amthor H; Isnard R; Malissen M; Schwartz K; Bonne G
    Hum Mol Genet; 2005 Jan; 14(1):155-69. PubMed ID: 15548545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathies.
    Nicolas HA; Bertrand AT; Labib S; Mohamed-Uvaize M; Bolongo PM; Wu WY; Bilińska ZT; Bonne G; Akimenko MA; Tesson F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.
    Sayed N; Liu C; Ameen M; Himmati F; Zhang JZ; Khanamiri S; Moonen JR; Wnorowski A; Cheng L; Rhee JW; Gaddam S; Wang KC; Sallam K; Boyd JH; Woo YJ; Rabinovitch M; Wu JC
    Sci Transl Med; 2020 Jul; 12(554):. PubMed ID: 32727917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular defects associated with antithrombin deficiency and dilated cardiomyopathy in a Japanese patient.
    Fujimori Y; Okimatsu H; Kashiwagi T; Sanda N; Okumura K; Takagi A; Nagata K; Murate T; Uchida A; Node K; Saito H; Kojima T
    Intern Med; 2008; 47(10):925-31. PubMed ID: 18480576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.